DR. GRADON NIELSEN M.D. NPI 1669868774

NPI Information

  • NPI: 1669868774
  • Provider Name: DR. GRADON NIELSEN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 6251 E VIRGINIA BEACH BLVD STE 200
    NORFOLK, VA
    ZIP 23502
  • Phone: (757) 466-8683

Map and Directions

Get Directions

NPI Details

DR. Gradon Nielsen, M.D. is a hematology and oncology internal medicine in Norfolk, VA with 11 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Gradon Nielsen, M.D. NPI is 1669868774. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE
Graduation Year:2015

The provider's business location address is:

6251 E VIRGINIA BEACH BLVD STE 200
NORFOLK, VA
ZIP 23502-824
Phone: (757) 466-8683

The NPI 1669868774 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, azacitidine, 1 mg (HCPCS:J9025)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, etoposide, 10 mg (HCPCS:J9181)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Protein measurement, serum (HCPCS:84165)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Uric acid level, blood (HCPCS:84550)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Unclassified drugs (HCPCS:J3490)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Urinalysis, manual test (HCPCS:81002)
  • Refilling and maintenance of portable pump (HCPCS:96521)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Phosphate level (HCPCS:84100)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)

The enumeration date for this NPI number is 4/15/2015 and was last updated on 8/5/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology0101271237VIRGINIAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.